305 related articles for article (PubMed ID: 25171871)
1. Comparative efficacy and safety of subcutaneous versus sublingual immunotherapy.
Bauer CS; Rank MA
J Allergy Clin Immunol; 2014 Sep; 134(3):765-765.e2. PubMed ID: 25171871
[No Abstract] [Full Text] [Related]
2. Efficacy of sublingual immunotherapy tablets in dust mite and pollen allergy.
Bisyuk Y; DuBuske I; DuBuske LM
Allergy Asthma Proc; 2021 Jan; 42(1):36-42. PubMed ID: 33404387
[TBL] [Abstract][Full Text] [Related]
3. Treatment of respiratory allergy with allergy immunotherapy tablets.
Bachert C
Allergy; 2011 Jul; 66 Suppl 95():57-9. PubMed ID: 21668858
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous Immunotherapy and Sublingual Immunotherapy: Comparative Efficacy, Current and Potential Indications, and Warnings--United States Versus Europe.
Nelson HS; Makatsori M; Calderon MA
Immunol Allergy Clin North Am; 2016 Feb; 36(1):13-24. PubMed ID: 26617224
[TBL] [Abstract][Full Text] [Related]
5. [Sublingual vs subcutaneous immunotherapy].
Olivé Pérez A
Rev Alerg Mex; 2004; 51(1):29-35. PubMed ID: 15119753
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous injection immunotherapy for optimal effectiveness.
Nelson HS
Immunol Allergy Clin North Am; 2011 May; 31(2):211-26, viii. PubMed ID: 21530815
[TBL] [Abstract][Full Text] [Related]
7. Allergen immunotherapy: an updated review of safety.
James C; Bernstein DI
Curr Opin Allergy Clin Immunol; 2017 Feb; 17(1):55-59. PubMed ID: 27906697
[TBL] [Abstract][Full Text] [Related]
8. Sublingual immunotherapy and subcutaneous immunotherapy: issues in the United States.
Greenberger PA; Ballow M; Casale TB; Platts-Mills TA; Sampson HA
J Allergy Clin Immunol; 2007 Dec; 120(6):1466-8. PubMed ID: 17936891
[No Abstract] [Full Text] [Related]
9. Specific immunotherapy with allergen mixes: what is the evidence?
Nelson HS
Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):549-53. PubMed ID: 19745727
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells in allergen-specific immunotherapy.
Novak N
Drugs Today (Barc); 2008 Dec; 44 Suppl B():91-2. PubMed ID: 19221629
[No Abstract] [Full Text] [Related]
11. Subcutaneous and sublingual immunotherapy and T regulatory cells: there is clinical relevance.
Ciprandi G; Morandi F; Olcese R; Silvestri M; Tosca MA
Clin Exp Allergy; 2010 Oct; 40(10):1578-9; author reply 1579-80. PubMed ID: 20937063
[No Abstract] [Full Text] [Related]
12. Epicutaneous immunotherapy.
Scheurer S; Toda M
Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():25-29. PubMed ID: 29108765
[No Abstract] [Full Text] [Related]
13. Safety of sublingual grass pollen immunotherapy after anaphylaxis.
Nichani JR; de Carpentier J
J Laryngol Otol; 2009 Jun; 123(6):683-4. PubMed ID: 18501039
[TBL] [Abstract][Full Text] [Related]
14. Specific immunotherapy by different allergen applications: subcutaneous, sublingual, oral or rectal administration and lymph node injection.
Kleine-Tebbe J
Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():87-95; discussion 95. PubMed ID: 20799448
[No Abstract] [Full Text] [Related]
15. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.
Kiel MA; Röder E; Gerth van Wijk R; Al MJ; Hop WC; Rutten-van Mölken MP
J Allergy Clin Immunol; 2013 Aug; 132(2):353-60.e2. PubMed ID: 23651609
[TBL] [Abstract][Full Text] [Related]
16. How does sublingual immunotherapy work?
Frew AJ
J Allergy Clin Immunol; 2007 Sep; 120(3):533-6. PubMed ID: 17765753
[No Abstract] [Full Text] [Related]
17. [New administration routes for immunotherapy].
Martorell Aragonés A
Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
[TBL] [Abstract][Full Text] [Related]
18. Adverse effects associated with sublingual immunotherapy.
Passalacqua G; Valovirta E
Clin Allergy Immunol; 2008; 21():469-75. PubMed ID: 18828524
[No Abstract] [Full Text] [Related]
19. Next generation immunotherapy for tree pollen allergies.
Su Y; Romeu-Bonilla E; Heiland T
Hum Vaccin Immunother; 2017 Oct; 13(10):2402-2415. PubMed ID: 28853984
[TBL] [Abstract][Full Text] [Related]
20. Sublingual immunotherapy for allergic respiratory diseases: efficacy and safety.
Passalacqua G; Canonica GW
Immunol Allergy Clin North Am; 2011 May; 31(2):265-77, ix. PubMed ID: 21530819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
